Alfasigma Denmark ApS: Financial statements 2024
CVR: 42447242
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Alfasigma Denmark ApS (CVR 42447242) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 9,532,078 and a net result of DKK 815,009 compared with DKK 1,389,584 the year before. That is a decrease of 19.1% compared with the year before. Equity in the 2024 report amounted to DKK 4,088,780. The solvency ratio was 27.4%. The company had 4 employees in the financial year.
- Gross Profit
- DKK 9,532,078
- Profit/Loss
- DKK 815,009
- Equity
- DKK 4,088,780
- Total Assets
- DKK 14,902,122
- Employees
- 4
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 9.5 mio. | 815 t. | 4.1 mio. | 4 |
| 2023 | - | 11.8 mio. | 1.4 mio. | 3.3 mio. | 6 |
| 2022 | - | 13.8 mio. | 1.4 mio. | 1.9 mio. | 6 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
As of September 15, 2024, Maria Chiara Cucchi is registered as director of Alfasigma Denmark ApS.
As of September 15, 2024, Samara Orsatti has stepped down as director of Alfasigma Denmark ApS.
On September 15, 2024, the company changed its name from Galapagos Biopharma Denmark ApS to Alfasigma Denmark ApS.
Alfasigma Denmark ApS has published its annual report for 2023. Gross profit came to DKK 11,777,533, and the net result was DKK 1,389,584.
As of January 31, 2024, Samara Orsatti is registered as director of Alfasigma Denmark ApS.
As of January 31, 2024, is registered as an owner of Alfasigma Denmark ApS with an ownership share of 100%.
As of January 25, 2024, Forvis Mazars Statsautoriseret Revisionspartnerselskab has been appointed auditor of Alfasigma Denmark ApS.
About Alfasigma Denmark ApS
Alfasigma Denmark ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2021. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named Galapagos Biopharma Denmark ApS. The management consists of Alberto Avaltroni, Alessio Battaglia and Line de Linde Henriksen. The company is owned by ALFASIGMA SpA. The company has 6 employees (2026). In 2025, the company reported a gross profit of DKK 10,680,660 and a net result of DKK 505,448 compared with DKK 815,009 the year before. Equity in the 2025 report amounted to DKK 4,594,228.